Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.6%

1 terminated/withdrawn out of 61 trials

Success Rate

92.3%

+5.8% vs industry average

Late-Stage Pipeline

18%

11 trials in Phase 3/4

Results Transparency

8%

1 of 12 completed trials have results

Key Signals

21 recruiting1 with results

Enrollment Performance

Analytics

N/A
16(36.4%)
Phase 2
14(31.8%)
Phase 4
7(15.9%)
Phase 3
4(9.1%)
Phase 1
2(4.5%)
Early Phase 1
1(2.3%)
44Total
N/A(16)
Phase 2(14)
Phase 4(7)
Phase 3(4)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (61)

Showing 20 of 61 trials
NCT07604688Recruiting

Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China

Role: collaborator

NCT07608224Phase 2Not Yet Recruiting

HOPE-07-MIBC: Disitamab Vedotin Plus Immunotherapy vs Chemoimmunotherapy in Resectable HER2-Expressing MIBC

Role: collaborator

NCT05129904Active Not Recruiting

Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)

Role: collaborator

NCT07587671Not ApplicableNot Yet Recruiting

Underdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in Cirrhosis

Role: collaborator

NCT07241793Phase 2Recruiting

Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)

Role: collaborator

NCT04518475Phase 4Recruiting

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

Role: collaborator

NCT07412171Phase 2Not Yet Recruiting

NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC

Role: collaborator

NCT06484374Not ApplicableRecruiting

A Multicenter, RAndomlzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With Al-assisted Robotic guidanCe for Hemorrhagic Stroke: Large Basal Ganglia Hemorrhage

Role: collaborator

NCT07406139Phase 4Recruiting

PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A）

Role: collaborator

NCT06107582Recruiting

Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)

Role: collaborator

NCT03664518Phase 2Completed

to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection

Role: collaborator

NCT03384277Phase 4Completed

Trial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab

Role: collaborator

NCT01719692Not ApplicableCompleted

Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia

Role: collaborator

NCT07239674Phase 3Not Yet Recruiting

Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC

Role: collaborator

NCT07237828Not ApplicableNot Yet Recruiting

Drain Removal on Postoperative Safety and Patient Satisfaction in R-E-NSM With Prepectoral DIBR

Role: collaborator

NCT04669496Phase 2Active Not Recruiting

Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

Role: collaborator

NCT06943729Recruiting

Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms

Role: collaborator

NCT05123625Not ApplicableRecruiting

Prognostic Effect of Whether Doing PLND During RC for High-risk NMIBC

Role: collaborator

NCT07063225Phase 2Recruiting

Romiplostim N01 for Chemotherapy-induced Thrombocytopenia

Role: collaborator

NCT07014501Recruiting

Study on the Correlation Mechanism and Application of Genetic Susceptibility, Hemoglobin Adaptation Changes, and Extubation Success Rate in Stroke Patients With Tracheotomy at Different Altitudes

Role: lead